Clinical Trials · NCT02605226
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Enrollment
- 240
- Start date
- Nov 2015
- Locations
- 1 site, China
- Primary endpoint
- Median PSA progression-free survival in patients responding to the study treatments